ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,500 | -62.1% | 25,000 | -60.9% | 0.04% | -59.2% |
| Q2 2023 | $236,160 | -28.7% | 64,000 | -36.0% | 0.10% | -30.5% |
| Q1 2023 | $331,000 | +12.6% | 100,000 | -17.4% | 0.14% | -15.1% |
| Q3 2022 | $294,000 | +48.5% | 121,000 | +21.0% | 0.17% | +72.9% |
| Q2 2022 | $198,000 | +8.2% | 100,000 | 0.0% | 0.10% | +33.3% |
| Q1 2022 | $183,000 | – | 100,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |